Search results
Novavax, Inc. (NVAX) vs. Its Peers: A Comparison – News Heater
NewsHeater· 6 days agoThere are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 2 rating it as “overweight,” 5 rating it as “hold,” and 0 rating it as “sell.” The public float for NVAX is 132.98M ...
The path to a better tuberculosis vaccine runs through Montana
The State· 15 hours agoA team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an infectious disease that has killed more people than any other. The ...
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Zacks via Yahoo Finance· 6 days agoLNTH is just one of a large group of Medical stocks with a positive ESP figure. Novavax (NVAX) is...
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition
InvestorPlace· 4 days agoIf you have a high tolerance for volatility then the biotech sector might be for you. Biotech stocks...
Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings
Zacks· 7 days agoThis means that investors might want to take advantage of these earnings surprises. Hunting for 'earnings whispers' or companies poised to beat their quarterly earnings estimates is a somewhat ...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 4 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Less than half of nursing home residents are up to date with their COVID-19 vaccines, study finds:...
Yahoo Life Style via AOL· 6 days agoHere’s your go-to guide with everything you need to know about COVID-19, including testing expanding...
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 6 days agoInvestor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine,...
UK virtually ends free vaccines as COVID-19 continues to spread
World Socialist Web Site· 7 days agoMore than four years since the UK reported its initial case of COVID-19, the virus continues to...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 4 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...